Cost Per Response for Abatacept Compared with Adalimumab In the Treatment of Patients with Rheumatoid Arthritis Based on Anti-Citrullinated Protein Antibody Titres In Italy
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.751
https://www.valueinhealthjournal.com/article/S1098-3015(17)31085-9/fulltext
Title :
Cost Per Response for Abatacept Compared with Adalimumab In the Treatment of Patients with Rheumatoid Arthritis Based on Anti-Citrullinated Protein Antibody Titres In Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31085-9&doi=10.1016/j.jval.2017.08.751
First page :
A531
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
715